scholarly article | Q13442814 |
P356 | DOI | 10.1158/0008-5472.CAN-06-3530 |
P698 | PubMed publication ID | 17363571 |
P2093 | author name string | Yan Wang | |
H Phillip Koeffler | |||
Dong Xie | |||
Xiang-Jun Tong | |||
Ping-Ping Chen | |||
Dong-Ping Liu | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2535-2543 | |
P577 | publication date | 2007-03-01 | |
P1433 | published in | Cancer Research | Q326097 |
P1476 | title | Involvement of IFN regulatory factor (IRF)-1 and IRF-2 in the formation and progression of human esophageal cancers | |
P478 | volume | 67 |
Q47149558 | A 17-molecule set as a predictor of complete response to neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal cancer |
Q34664105 | Altered gene expression patterns during the initiation and promotion stages of neonatally diethylstilbestrol-induced hyperplasia/dysplasia/neoplasia in the hamster uterus |
Q27028000 | An immunologic portrait of cancer |
Q91776666 | Anti-apoptotic effect by the suppression of IRF1 as a downstream of Wnt/β-catenin signaling in colorectal cancer cells |
Q91741807 | BUB1 promotes proliferation of liver cancer cells by activating SMAD2 phosphorylation |
Q42086447 | Bleomycin hydrolase is regulated biphasically in a differentiation- and cytokine-dependent manner: relevance to atopic dermatitis |
Q39248328 | DNA-binding regulates site-specific ubiquitination of IRF-1. |
Q54531321 | EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex. |
Q34333453 | Exploring molecular links between lymph node invasion and cancer prognosis in human breast cancer. |
Q92308905 | Expression levels of EPHB4, EFNB2 and caspase-8 are associated with clinicopathological features and progression of esophageal squamous cell cancer |
Q55440708 | FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma. |
Q38353654 | Functional characterization of SAMD9, a protein deficient in normophosphatemic familial tumoral calcinosis |
Q92354144 | Genome-Wide Tiling Array Analysis of HPV-Induced Warts Reveals Aberrant Methylation of Protein-Coding and Non-Coding Regions |
Q47805023 | Hyperactive mTOR induces neuroendocrine differentiation in prostate cancer cell with concurrent up-regulation of IRF1. |
Q38916641 | IFNg-induced Irgm1 promotes tumorigenesis of melanoma via dual regulation of apoptosis and Bif-1-dependent autophagy |
Q39436841 | IRF-2 is over-expressed in pancreatic cancer and promotes the growth of pancreatic cancer cells |
Q37036342 | Immune mediators regulate CFTR expression through a bifunctional airway-selective enhancer |
Q38408962 | Innate Immune Responses in ALV-J Infected Chicks and Chickens with Hemangioma In Vivo |
Q39313078 | Interferon regulatory factor (IRF)-1 and IRF-2 are associated with prognosis and tumor invasion in HCC. |
Q39744237 | Interferon regulatory factor (IRF)-2 activates the HPV-16 E6-E7 promoter in keratinocytes |
Q55162579 | Interferon regulatory factor 1 inactivation in human cancer. |
Q33743822 | Interferon regulatory factor 1 restricts gammaherpesvirus replication in primary immune cells |
Q34185316 | Interferon regulatory factor 2 binding protein 2 is a new NFAT1 partner and represses its transcriptional activity. |
Q36366414 | Interferon-γ induces autophagy with growth inhibition and cell death in human hepatocellular carcinoma (HCC) cells through interferon-regulatory factor-1 (IRF-1) |
Q38963640 | Involvement of chromosome region maintenance 1 (CRM1) in the formation and progression of esophageal squamous cell carcinoma |
Q88623337 | Long non-coding RNA GAS5 is induced by interferons and plays an antitumor role in esophageal squamous cell carcinoma |
Q38853147 | MicroRNA-18a modulates P53 expression by targeting IRF2 in gastric cancer patients |
Q38687774 | MicroRNA-18a-5p functions as an oncogene by directly targeting IRF2 in lung cancer. |
Q37635639 | MicroRNA-520c enhances cell proliferation, migration, and invasion by suppressing IRF2 in gastric cancer |
Q33900865 | Minicircle-oriP-IFNγ: a novel targeted gene therapeutic system for EBV positive human nasopharyngeal carcinoma |
Q38335277 | Mouse interferon regulatory factor-2: expression, purification and DNA binding activity |
Q38694375 | Nasopharyngeal carcinoma super-enhancer-driven ETV6 correlates with prognosis |
Q34443056 | Pegylated IFN-α sensitizes melanoma cells to chemotherapy and causes premature senescence in endothelial cells by IRF-1 mediated signaling |
Q33889034 | Prognostic value of IRF-2 expression in colorectal cancer |
Q54369247 | Replacement of the C-terminal tetrapeptide (314 PAPV 317 to 314 SSSM 317) in interferon regulatory factor-2 alters its N-terminal DNA-binding activity. |
Q27000047 | Research advances at the Institute for Nutritional Sciences at Shanghai, China |
Q39910817 | The novel p53 target gene IRF2BP2 participates in cell survival during the p53 stress response |
Q35044062 | Transcriptional regulation of the major HIV-1 coreceptor, CXCR4, by the kappa opioid receptor |
Q39602832 | Tumor Suppressor Interferon-Regulatory Factor 1 Counteracts the Germinal Center Reaction Driven by a Cancer-Associated Gammaherpesvirus |
Q57813970 | Tumor suppressor Interferon Regulatory Factor 1 selectively blocks expression of endogenous retrovirus |
Q58051484 | Unique genetic profile of sporadic colorectal cancer liver metastasis versus primary tumors as defined by high-density single-nucleotide polymorphism arrays |
Q41472283 | miR-302b inhibits cancer-related inflammation by targeting ERBB4, IRF2 and CXCR4 in esophageal cancer |
Search more.